GlassScriptPhysician profile
Rori Dajao
NPI 1508300591
$844.72
in general payments reported to CMS, 2019-2025
8 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $13.86 · 2021: $190 · 2022: $111 · 2024: $146 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $362.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $300.73 | 2021-2022 | |
| Abbvie INC. | $181.34 | 2019-2020 | |
| Hologic Sales and Service, LLC | $149.55 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $98.24 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $52.65 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Getinge USA Sales, LLC | $26.90 | 2024 | Maquet Powerled II |
| Merck Sharp & Dohme LLC | $19.00 | 2024 | Gardasil 9, Gardasil |
| Mayne Pharma Commercial LLC | $16.31 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rori Dajao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.